2024 annual financial data
Gain Therapeutics 2024 Operating margin
Gain Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -20,350,592 USD and net income was -20,411,191 USD.
Operating cash flow was -18,873,827 USD.
Get free Gain Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -20,350,592 USD
- Net income
- -20,411,191 USD
- Operating cash flow
- -18,873,827 USD